Cara Therapeutics (CARA) Set to Join S&P SmallCap 600

Cara Therapeutics Inc. (NASDAQ: CARA) will replace MTS Systems Corp. (NASDAQ: MTSC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 8. S&P 500 constituent Amphenol Corp. (NYSE: APH) is acquiring MTS Systems in a deal expected to be completed soon pending final closing conditions.

You May Also Be Interested In

• Lumen Technologies (LUMN) to cut 7% staff
• Day One Biopharmaceuticals' (DAWN) OJEMDA Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
• Renasant Corp. (RNST) Announces Leadership Transition